| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Garland J. Scott | Director | C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO | /s/ Shelly Pinto, by power of attorney | 21 Jan 2026 | 0001533228 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALXO | Stock option (right to buy) | Award | $0 | +40,400 | $0.000000 | 40,400 | 20 Jan 2026 | Common Stock | 40,400 | $1.32 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026. |